Skip to main content
Clinical Trials/NCT04010409
NCT04010409
Recruiting
Not Applicable

Mindreading in Adults With Autism Spectrum Disorder

National Taiwan University Hospital1 site in 1 country60 target enrollmentJanuary 8, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Autism Spectrum Disorder
Sponsor
National Taiwan University Hospital
Enrollment
60
Locations
1
Primary Endpoint
eye tracking indicators
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

This study aims to investigate the ability of reading emotions by the Eyes task in adults with ASD, and examine the gazing pattern and frontal activation during the task. We plan to recruit 50 adults with ASD and 50 typically-developing adults. Eye-tracking and frontal activation (measured by functional near-infrared spectroscopy) will be examined during the Eyes task.

Detailed Description

Autism spectrum disorder (ASD) is a clinical syndrome characterized by mindreading deficits, or Theory of Mind deficits. The Reading the Mind in the Eyes task (abbreviated as the Eyes task) was developed to assess the mindreading deficits as a hallmark of social deficits of ASD. This study aims to investigate the ability of reading emotions by the Eyes task in adults with ASD, and examine the gazing pattern and frontal activation during the task. We plan to recruit 50 adults with ASD and 50 typically-developing adults. All the participants will complete clinical measures and the Eyes task. Eye-tracking and frontal activation (measured by functional near-infrared spectroscopy) will be examined during the Eyes task.

Registry
clinicaltrials.gov
Start Date
January 8, 2019
End Date
December 31, 2024
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult aged between 20 and 50 years who had a diagnosis of ASD based on DSM-
  • Had a full-scale IQ \> 70 on WAIS-IV.

Exclusion Criteria

  • A history of major mental illness (e.g., bipolar affective disorder, schizophrenia) or neurological diseases.
  • Visual impairment and that would preclude participation.

Outcomes

Primary Outcomes

eye tracking indicators

Time Frame: 30 min

eye tracking indicators

Study Sites (1)

Loading locations...

Similar Trials